Systemic Regulation of RAS/MAPK Signaling by the Serotonin Metabolite 5-HIAA

Tobias Schmid1, L Basten Snoek2, Erika Fröhli3

  • 1University of Zurich, Institute of Molecular Life Sciences, Zurich, Switzerland; PhD Program in Molecular Life Sciences, University and ETH Zurich, Zurich, Switzerland.

Plos Genetics
|May 16, 2015
PubMed

Insights

Genetic background influences cancer by modifying oncogenic pathways. In C. elegans, monoamine oxidase A (MAOA) activity regulates the RAS/MAPK pathway via the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA).

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Human cancer arises from mutations in oncogenes, tumor suppressor genes, and inherited variations.
  • The influence of genetic background on cancer onset and progression remains incompletely understood.
  • The RAS/MAPK signaling pathway is frequently implicated in oncogenesis.

Purpose of the Study:

  • To identify genetic modifiers of the oncogenic RAS/MAPK signaling pathway using C. elegans.
  • To elucidate the role of genetic background in regulating pathway activity.
  • To discover novel endogenous regulators of RAS/MAPK signaling.

Main Methods:

  • Utilized C. elegans genetics for modifier screening.
  • Performed quantitative trait locus (QTL) analysis on diverged C. elegans isolates.
  • Conducted allele swapping experiments to validate gene function.
  • Measured levels of serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA).

Main Results:

  • Identified the monoamine oxidase A (MAOA) gene, specifically amx-2, as a negative regulator of RAS/MAPK signaling.
  • Demonstrated that 5-hydroxyindoleacetic acid (5-HIAA), a product of MAOA, acts as a systemic inhibitor of RAS/MAPK signaling.
  • Established that MAOA activity modulates 5-HIAA levels, thereby setting a global threshold for MAPK activation.

Conclusions:

  • MAOA and its metabolite 5-HIAA are critical endogenous regulators of RAS/MAPK signaling.
  • MAOA activity provides a systemic mechanism to control MAPK pathway activation.
  • This study identifies 5-HIAA as the first known endogenous small molecule inhibitor of RAS/MAPK signaling.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K